These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 14143003)

  • 1. [PLACE OF ALDACTONE IN THE THERAPY OF EDEMA].
    APARICIO
    J Med Bord; 1964 Feb; 141():245-54. PubMed ID: 14143003
    [No Abstract]   [Full Text] [Related]  

  • 2. [Aldactone (antialdosterone SC-9420) in the treatment of the edema of cardiac and cirrhoticpatients. Bioclinical study. I].
    PAGET M; LANGERON L; CROCCEL L; ROUTIER G; CROCCEL E
    Ann Biol Clin (Paris); 1962; 20():497-524. PubMed ID: 14483184
    [No Abstract]   [Full Text] [Related]  

  • 3. [Aldactone (aldosterone antagonist SC-9, 420) in the treatment of the edemas of heart patients and cirrhotic patients. Bioclinical study].
    PAGET M; LANGERON L; CROCCEL L; ROUTIER G; CROCCEL E; PROTIN M
    J Sci Med Lille; 1962 May; 80():225-35. PubMed ID: 14483183
    [No Abstract]   [Full Text] [Related]  

  • 4. [Physiological bases of the utilization of aldosterone antagonists. Their clinical applications].
    VAN CAUWENBERGE H; LEFEBVRE P
    Acta Cardiol; 1962; 17():627-56. PubMed ID: 13995980
    [No Abstract]   [Full Text] [Related]  

  • 5. [SECONDARY HYPERALDOSTERONISM. PHYSIOPATHOLOGIC, CLINICAL AND THERAPEUTIC CONSIDERATIONS].
    DEMARTINIS C; FONZO D
    Clin Ter; 1963 Oct; 27():51-72. PubMed ID: 14097444
    [No Abstract]   [Full Text] [Related]  

  • 6. [Tissular aldactone saliuretic inhibitor of aldosterone. Its significance in the treatment of edemas associated with secondary hyperaldosteronism].
    MURISASCO A; REYNAUD M; BOUISSON M
    Sem Hop; 1961 Dec; 37():3421-5. PubMed ID: 14477376
    [No Abstract]   [Full Text] [Related]  

  • 7. SECONDARY ALDOSTERONISM AND REFRACTORY OEDEMATOUS STATES.
    STEINBECK AW
    Bull Postgrad Comm Med Univ Syd; 1963 Nov; 19():208-13. PubMed ID: 14082846
    [No Abstract]   [Full Text] [Related]  

  • 8. [RESULTS OF EXPERIMENTATION WITH A MICRONIZED ALDACTONE (8013 MCB) AND SULFONAMIDE DIURETIC (8093 CB) COMBINATION IN THE TREATMENT OF EDEMA].
    KISSEL P; DUREUX JB; SCHMITT J
    Ann Med Nancy; 1963 Nov; 2():1543-50. PubMed ID: 14111518
    [No Abstract]   [Full Text] [Related]  

  • 9. ALDOSTERONE IN CLINICAL MEDICINE.
    BIGLIERI EG; SLATON PE
    Calif Med; 1964 Sep; 101(3):191-5. PubMed ID: 14204551
    [No Abstract]   [Full Text] [Related]  

  • 10. [THE TREATMENT OF EDEMA WITH SULFONAMIDE DIURETICS].
    BAGROS P
    Vie Med; 1964 Jan; 45():109-24. PubMed ID: 14128589
    [No Abstract]   [Full Text] [Related]  

  • 11. [Spirolactone. Its use in the treatment of cardiac and cirrhotic edema. Apropos of 6 case reports].
    JUSTIN-BESANCON L; LAROCHE C; NENNA A; ETIENNE JP; CREMER G
    Sem Hop Ther Paris; 1961 Mar; 37():197-211. PubMed ID: 13791127
    [No Abstract]   [Full Text] [Related]  

  • 12. High doses of spironolactone (Aldactone, SC-14266, Verospirone) alone and in combination with triamterene and-or diuretics in the treatment of refractory edema associated with secondary hyperaldosteronism.
    Radó JP; Marosi J; Takó J
    Endokrinologie; 1970; 57(1):46-62. PubMed ID: 4923990
    [No Abstract]   [Full Text] [Related]  

  • 13. [MEASUREMENT OF ALDOSTERONE SECRETION DURING THE ADMINISTRATION OF A SEMI-SYNTHETIC ADRENOSTATIC AGENT, HEPARINOID RO I-8307].
    VEYRAT R; MANNING EL; FABRE J; MULLER AF
    Rev Fr Etud Clin Biol; 1963; 8():667-73. PubMed ID: 14082398
    [No Abstract]   [Full Text] [Related]  

  • 14. Sodium retention in heart failure and cirrhosis: potential role of natriuretic doses of mineralocorticoid antagonist?
    Bansal S; Lindenfeld J; Schrier RW
    Circ Heart Fail; 2009 Jul; 2(4):370-6. PubMed ID: 19808361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [ACTION OF SPIRONOLACTONE IN THE TREATMENT OF EDEMA OF SECONDARY ALDOSTERONISM].
    BERCONSKY I; NIJENSOHN CM; BRUNO PL
    Prensa Med Argent; 1965 Mar; 52():472-6. PubMed ID: 14325124
    [No Abstract]   [Full Text] [Related]  

  • 16. Aldosterone antagonists in hypertension and heart failure.
    Mantero F; Lucarelli G
    Ann Endocrinol (Paris); 2000 Feb; 61(1):52-60. PubMed ID: 10790593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Studies on the urinary excretion of aldosterone. II. On the role of aldosterone in the pathogenesis of some clinical syndromes].
    DE MARTINIS C; FONZO D
    Folia Endocrinol Mens Incretologia Incretoterapia; 1962 Jun; 15():316-37. PubMed ID: 14025920
    [No Abstract]   [Full Text] [Related]  

  • 18. [ALDOSTERONE IN EDEMA SYNDROME. HYPERALDOSTERONISM IN CONGESTIVE CARDIAC INSUFFICIENCY].
    LABOS I
    Med Glas; 1964 Sep; 18():275-9. PubMed ID: 14275737
    [No Abstract]   [Full Text] [Related]  

  • 19. ALDOSTERONE AND THE EDEMA OF CONGESTIVE HEART FAILURE.
    GOLDBERGER E
    Am J Cardiol; 1965 Feb; 15():274. PubMed ID: 14254821
    [No Abstract]   [Full Text] [Related]  

  • 20. [ON THE DIURETIC EFFECT OF THE ADRENOSTATIC DRUG METHOPYRAPONE].
    HIERHOLZER K
    Dtsch Med Wochenschr; 1964 Jun; 89():1167-73. PubMed ID: 14152375
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.